USING MASS SPEC TO DETERMINE MOLECULAR IDENTITY OF TUMOR SPECIFIC ANTIGEN

使用质谱确定肿瘤特异性抗原的分子身份

• 批准号: 8363749
• 负责人: James D. Marks
• 金额: --
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-06-01 至 2012-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8363749
• 关键词: Antibodies; Antigen Targeting; Bacteriophages; Binding; Cancer Biology; Funding; Grant; Immunoprecipitation; Immunotherapeutic agent; Lead; Malignant neoplasm of prostate; Mass Spectrum Analysis; Methods; Molecular; National Center for Research Resources; Phage Display; Principal Investigator; Research; Research Infrastructure; Resources; Source; Tumor Antigens; United States National Institutes of Health; cancer cell; cost; human monoclonal antibodies; novel; protein aminoacid sequence; tandem mass spectrometry

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Antibody phage display is a useful method of developing fully human monoclonal antibodies against both known and novel tumor antigens. We have obtained over 70 phage antibodies that specifically bind to and internalize within prostate cancer cells. Uncovering their molecular identities will lead to better understanding of cancer biology and better assessment of these molecules as targets for targeted immunotherapeutics. We propose to use immunoprecipitation and tandem mass spectrometry to obtain peptide sequences of antigens targeted by the antibodies.

这个子项目是利用这些资源的众多研究子项目之一